Vattai, Aurelia
Kremer, Nadine
Meister, Sarah
Beyer, Susanne
Keilmann, Lucia
Hester, Anna
Temelkov, Mina
Heidegger, Helene
Schmoeckel, Elisa
Kessler, Mirjana
Mahner, Sven
Jeschke, Udo
Hertlein, Linda
Kolben, Thomas
Funding for this research was provided by:
Friedrich-Baur-Stiftung
Article History
Received: 24 August 2021
Accepted: 14 September 2021
First Online: 5 November 2021
Declarations
:
: Sven Mahner: Research support, advisory board Honoria and travel expenses from AbbVie, Astra Zeneca, Clovis, Eisai, GSK, Medac, MSD, Novartis, Olympus, PharmaMar, Roche, Sensor Kinesis, Teva, Tesaro. Thomas Kolben: Holding stocks of Roche AG, relative working at Roche AG. Anna Hester: Honoraria and travel expenses from Pfizer, Honoraria from Roche, Research funding from “Walter-Schulz-Stiftung”.
: All patients gave informed consent prior to study participation. All procedures were performed according to the ethical standards of the institutional and/or national research committee and with the declaration of Helsinki of 1964 and its later amendments. This study was approved by the local ethics committee of the Ludwig-Maximilians-University Munich, Germany (167-14).
: Informed consent was obtained from all individual participants included in this study.
: Informed consent was obtained from all individual participants included in this study.